Skip to main content
Clinical Trials/CTRI/2017/11/010355
CTRI/2017/11/010355
Active, not recruiting
Phase 4

The comparison of the effects of dexmedetomidine, esmolol and combination of dexmedetomidine with esmolol to attenuatehemodynamic response to endotracheal intubation in patientsundergoing CABG.

Vydehi Institute of Medical Sciences and Research Centre0 sites120 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Health Condition 1: null- Adult patients with ASA 1and 2 physical status scheduled for cardiac surgery
Sponsor
Vydehi Institute of Medical Sciences and Research Centre
Enrollment
120
Status
Active, not recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Vydehi Institute of Medical Sciences and Research Centre

Eligibility Criteria

Inclusion Criteria

  • Adult patients with ASA 1and 2 physical status scheduled for cardiac surgery

Exclusion Criteria

  • Exclusion criteria included anticipated difficult intubation, emergency surgery, left ventricular ejection fraction \<40%, left ventricular aneurysm, associated valvular lesions, left main coronary artery disease, severe systemic diseases involving the renal and hepatic systems, preoperative left bundle branch block, chronic obstructive pulmonary disease and intubation attempt lasting longer than 20 seconds.

Outcomes

Primary Outcomes

Not specified

Similar Trials